Darkening under the eye.
Conditions
Interventions
Intervention 1: Intervention group: Patients use 1 cc liposomal hyaluronic acid (Zist Sakht Bonyan Pars Company) products topically in the area under the eyes once a day for three months. Intervention
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
21 Years to 60 Years
Inclusion criteria
Inclusion criteria: Darkness and wrinkles in the lower eyelid area, which need to be treated according to the opinion of the hospital doctor and the patient's desire.
Exclusion criteria
Exclusion criteria: Patients who had undergone previous surgery in the eyelid area Have had previous minimally invasive treatments such as botulinum toxin or fillers in the eyelid area. Patients with active skin disorders or inflammation, acute or chronic infection, tumors or cancer Patients under anticoagulant treatment smokers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of darkness under the eyes. Timepoint: prior to treatment, three and six months after the last treatment session. Method of measurement: VisioFace device.;The amount of wrinkles under the eyes. Timepoint: prior to treatment, three and six months after the last treatment session. Method of measurement: Visioface. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: prior to treatment, three months and six months after the last treatment session. Method of measurement: Standard questionnaires visual analogue scale (VAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSona Zare
Skin and Stem Cell Research Center, Tehran University of Medical Sciences
Outcome results
None listed